AN ACT RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES
Referred to House Health & Human Services
Email me when SB 2863 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 2863. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would mandate that private health plans and the state Medicaid program dispense up to 365 days of FDA‑approved prescription hormone therapy as a single prescription, starting in 2027. It defines the therapy, excludes GLP‑1 drugs, and applies to most health‑insurance policies except limited‑benefit plans. The measure failed in the Senate and was sent to the House Health & Human Services Committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 2863
3 free questions a day, no accountHistory
- 06/05/2026 Referred to House Health & Human Services
- 06/04/2026 Senate read and passed
- 06/02/2026 Placed on Senate Calendar (06/04/2026)
- 06/02/2026 Committee recommends passage
- 05/29/2026 Scheduled for consideration (06/02/2026)
- 04/07/2026 Committee recommended measure be held for further study
- 04/03/2026 Scheduled for hearing and/or consideration (04/07/2026)
- 03/04/2026 Introduced, referred to Senate Health and Human Services
Sponsors
- Murray (D) · sponsor
- DiMario
- Euer
- Gu
- Lauria
- Mack
- Ujifusa
- Urso
- Valverde
- Vargas
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 2863 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 2863 freeOr ask your AI assistant about SB 2863 directly:
Add to Claude, ChatGPT or Cursor